StockNews.com Begins Coverage on bluebird bio (NASDAQ:BLUE)
Analysts at StockNews.com began coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Several other research analysts have also issued reports on the stock. Barclays upped their target price on shares of bluebird bio from […]
Analysts at StockNews.com began coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a research note issued on Tuesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Several other research analysts have also issued reports on the stock. Barclays upped their target price on shares of bluebird bio from […]
